NICE Recommends MSD’s Welireg for Treating Rare Genetic Condition, Von Hippel-Lindau Disease
Welireg (belzutifan), developed by MSD (known as Merck & Co in the US and Canada), has...
Read MoreSelect Page
Posted by Admin | Sep 8, 2024 | Health Economics, Regulatory, Regulatory Update
Welireg (belzutifan), developed by MSD (known as Merck & Co in the US and Canada), has...
Read More